Polymorphic epithelial mucin from the sera of advanced breast cancer patients--isolation and partial characterisation.

The anti-breast carcinoma monoclonal antibody (MAb), NCRC-11 defines a polymorphic epithelial mucin (PEM) which is elevated in the circulation of advanced breast carcinoma patients. Here we describe the purification and partial characterisation of this component from patients' sera and its use...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Sullivan, C., Price, M. R., Baldwin, R. W.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1990
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971673/
https://www.ncbi.nlm.nih.gov/pubmed/1695521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971673/
https://www.ncbi.nlm.nih.gov/pubmed/1695521

Ejemplares similares